Updates are available Correction dated 2022-02-04
Click to view Correction: https://doi.org/10.1038/s41591-022-01730-5
-
Authors
Stock, Sarah J. http://orcid.org/0000-0003-4308-856X
Carruthers, Jade
Calvert, Clara
Denny, Cheryl http://orcid.org/0000-0003-4616-4732
Donaghy, Jack
Goulding, Anna http://orcid.org/0000-0002-1288-3256
Hopcroft, Lisa E. M.
Hopkins, Leanne
McLaughlin, Terry
Pan, Jiafeng
Shi, Ting http://orcid.org/0000-0002-4101-4535
Taylor, Bob http://orcid.org/0000-0003-4314-2685
Agrawal, Utkarsh
Auyeung, Bonnie
Katikireddi, Srinivasa Vittal http://orcid.org/0000-0001-6593-9092
McCowan, Colin
Murray, Josie
Simpson, Colin R. http://orcid.org/0000-0002-5194-8083
Robertson, Chris
Vasileiou, Eleftheria
Sheikh, Aziz http://orcid.org/0000-0001-7022-3056
Wood, Rachael
- License Information
-
More Information
Article History
Received: 4 November 2021
Accepted: 20 December 2021
First Online: 13 January 2022
Change Date: 4 February 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-022-01730-5
Competing interests
: A.S. and C.R. are members of the Scottish Government’s COVID-19 Advisory Group. A.S. and C.R. are members of the New and Emerging Respiratory Virus Threats Advisory Group risk stratification subgroup. C.R. is a member of the Scientific Pandemic Influenza Group on Modeling. A.S. is a member of AstraZeneca’s Thrombotic Thrombocytopenic Advisory Group. All roles are unremunerated. R.W. and C.R. are employed by Public Health Scotland. S.J.S. has received research grants paid to the institution from Wellcome Trust, Scottish Chief Scientist Office, National Institute of Healthcare Research and Tommy’s during the course of this study. The remaining authors declare no competing interests.
